| Targeting HMG-CoA reductase with statins in a window-of-opportunity breast cancer trial O Bjarnadottir, Q Romero, PO Bendahl, K Jirström, L Rydén, N Loman, ... Breast cancer research and treatment 138, 499-508, 2013 | 254 | 2013 |
| Statin-induced anti-proliferative effects via cyclin D1 and p27 in a window-of-opportunity breast cancer trial M Feldt, O Bjarnadottir, S Kimbung, K Jirström, PO Bendahl, S Veerla, ... Journal of translational medicine 13, 1-11, 2015 | 102 | 2015 |
| Statins: a role in breast cancer therapy? S Borgquist, O Bjarnadottir, S Kimbung, TP Ahern Journal of internal medicine 284 (4), 346-357, 2018 | 86 | 2018 |
| Global transcriptional changes following statin treatment in breast cancer O Bjarnadottir, S Kimbung, I Johansson, S Veerla, M Jönsson, ... Clinical Cancer Research 21 (15), 3402-3411, 2015 | 69 | 2015 |
| Statin use, HMGCR expression, and breast cancer survival–The Malmö Diet and Cancer Study O Bjarnadottir, M Feldt, M Inasu, PO Bendahl, K Elebro, S Kimbung, ... Scientific reports 10 (1), 558, 2020 | 46 | 2020 |
| Statins, HMGCR and Breast Cancer O Bjarnadottir | 1 | 2017 |
| Abstract PD03-07: Statin-induced decrease in proliferation depends on HMG-CoA reductase expression in breast cancer O Bjarnadottir, Q Romero, PO Bendahl, L Ryden, C Rose, N Loman, ... Cancer Research 72 (24_Supplement), PD03-07-PD03-07, 2012 | 1 | 2012 |
| Abstract OT2-30-01: Nordictrip, a translational randomized phase-3study exploring the effect of the addition of capecitabine to carboplatinum-based chemotherapy in early … N Loman, B Linderholm, J Ahlgren, S Kimbung, L Zander, HG Magnusson, ... Cancer Research 82 (4_Supplement), OT2-30-01-OT2-30-01, 2022 | | 2022 |
| Breast health at a critical juncture OK Bjarnadottir, SL Rafnsdottir LAEKNABLADID 107 (10), 493-493, 2021 | | 2021 |
| Statin-Induced Anti-Proliferative Effects via Cyclin D1 and P27 in a Window-of-Opportunity Breast Cancer Trial M Feldt, O Bjarnadottir, P Bendahl, K Jirström, D Grabau, I Hedenfalk, ... Annals of Oncology 25, i25, 2014 | | 2014 |
| BAG-1 in Core Biopsies, Tissue Microarrays and Surgical Samples–Investigation of a Novel Apoptosis Biomarker in Two Independent Breast Cancer Cohorts Q Romero, O Bjarnadottir, P Bendahl, M Klintman, M Fernö, D Grabau, ... Annals of Oncology 24, iii29, 2013 | | 2013 |
| Changes in Gene Expression Profiles Following Pre-Surgical Statin Treatment in a Window-of-Opportunity Breast Cancer Trial O Bjarnadottir, I Johansson, Q Romero, P Bendahl, C Rose, K Jirström, ... Annals of Oncology 24, iii25, 2013 | | 2013 |
| 72PBAG-1 IN CORE BIOPSIES, TISSUE MICROARRAYS AND SURGICAL SAMPLES–INVESTIGATION OF A NOVEL APOPTOSIS BIOMARKER IN TWO INDEPENDENT BREAST CANCER COHORTS Q Romero, O Bjarnadottir, P Bendahl, M Klintman, M Fernö, D Grabau, ... Annals of oncology 24 (suppl_3), iii34-iii35, 2013 | | 2013 |
| 49PCHANGES IN GENE EXPRESSION PROFILES FOLLOWING PRE-SURGICAL STATIN TREATMENT IN A WINDOW-OF-OPPORTUNITY BREAST CANCER TRIAL O Bjarnadottir, I Johansson, Q Romero, P Bendahl, C Rose, K Jirström, ... Annals of oncology 24 (suppl_3), iii27-iii27, 2013 | | 2013 |
| Brjóstaheilsa á tímamótum ÓK Bjarnadóttir, SL Rafnsdóttir | | |
